HexemBio

Stub active Updated Apr 6, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location New York, NY
Latest Stage Seed
Total Raised $10.4M
Website https://www.hexembio.com
Sector
biotech healthcare anti-aging

Founders

Gabriel Levesque-Tremblay CEO & Co-Founder
Samira Kiani Co-Founder
Mo Ebrahimkhani Co-Founder
Joshua Hislop Co-Founder

About

HexemBio is a biotech startup focused on stem cell rejuvenation technology 1. The company’s approach involves extracting blood stem cells (Hematopoietic Stem Cells) from a patient’s bone marrow, rejuvenating them in the lab, and returning them intravenously 1. HexemBio is initially targeting bone marrow transplant failure, and in preclinical studies has reduced transplant failure by up to 10x in mice 1. The company is an IndieBio (SOSV) portfolio company 2.

Funding History

Date Round Amount Lead Co-investors
2026-04-06 Seed $10.4M Draper Associates Gaingels, SOSV 12

What Investors Say

No verified investor quotes available at this time.

What Founders Say

No verified founder quotes available at this time.

Sources

  1. Axios Pro, “HexemBio raises $9.35M seed: Stem cell rejuvenation, anti-aging, cancer,” April 6, 2026. https://www.axios.com/pro/biotech-deals/2026/04/06/hexembio-raises-9m-seed-stem-cell-rejuvenation-aging-cancer↩↩↩↩

  2. IndieBio, “heXembio company page,” accessed April 2026. https://indiebio.co/company/hexembio/↩↩